Liver problems and BTK

Maxwell CR, Turner TJ, Wallstroem E, Patel S, Pappas SC, Lewis JH, Andrade RJ, Syed S. Tolebrutinib liver safety: A detailed overview. Mult Scler Relat Disord. 2026;113:107404. Tolebrutinib is an oral brain-penetrant Bruton s tyrosine kinase inhibitor thought to modulate persistent maladaptive immune activation within the CNS. It was evaluated in four Phase 3 trials and [ ]